In these lymphomas, miR-31-5p was shown to be associated with activation of the nuclear factor (NF)-κB pathway, a signaling pathway often deregulated in several types of malignancies, by targeting NF-κB inducing kinase [45]. The gene discussed is NFKB1; the disease is lymphoma.